Solventum Corporation (SOLV) Net Profit Margin: 17.33%
Is Solventum Corporation’s net profit margin high or low?
Solventum Corporation's net profit margin of 17.33% is 14% above its 5-year average of 15.15%, near the high end of its 5-year range (5.80%–18.69%).
As of Friday, June 12, 2026. 41.53% above its 12-month average of 12.25%.
SOLV Net Profit Margin Chart
SOLV Average Net Profit Margin Chart
SOLV Current vs Average Net Profit Margin Chart
SOLV Net Profit Margin Metrics
NET PROFIT MARGIN
17.33%
NET PROFIT MARGIN AVG TTM
12.25%
NET PROFIT MARGIN AVG 3Y
14.36%
NET PROFIT MARGIN AVG 5Y
15.15%
NET PROFIT MARGIN AVG 10Y
15.15%
NET PROFIT MARGIN AVG 15Y
15.15%
NET PROFIT MARGIN AVG 20Y
15.15%
CURRENT VS TTM AVG
+41.53%
CURRENT VS 3Y AVG
+20.70%
CURRENT VS 5Y AVG
+14.35%
CURRENT VS 10Y AVG
+14.35%
CURRENT VS 15Y AVG
+14.35%
CURRENT VS 20Y AVG
+14.35%
SOLV Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 17.33% | 12.25% | 14.36% | 15.15% |
| Align Technology, Inc. (ALGN) | $12.64B | 10.50% | 10.36% | 10.48% | 22.21% |
| Baxter International Inc. (BAX) | $10.58B | -9.70% | -7.30% | -3.29% | 1.14% |
| Hologic, Inc. (HOLX) | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | -4.59% | -1.67% | 5.09% | 7.31% |
| Tempus AI, Inc. (TEM) | $8.65B | -22.20% | -60.53% | -62.93% | -77.31% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 6.52% | -21.22% | -48.94% | 16.61% |
| Moderna, Inc. (MRNA) | $19.70B | -143.55% | -128.24% | -70.25% | -50.87% |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | -0.56% | 7.00% | -0.29% | -8.82% |
| BioNTech SE (BNTX) | $22.39B | -44.73% | -31.89% | 3.77% | 12.08% |
Margin Comparison
Operating Margin
25.5%
Net Profit Margin
17.3%
Solventum Corporation Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Net Profit Margin FAQ
- What is the net profit margin for Solventum Corporation (SOLV)?
- The net profit margin for SOLV stock is 17.33%.
- Is Solventum Corporation's net profit margin high or low?
- Solventum Corporation's net profit margin of 17.33% is 14% above its 5-year average of 15.15%, near the high end of its 5-year range (5.80%–18.69%).
- What is the TTM average net profit margin for Solventum Corporation (SOLV)?
- The TTM average net profit margin for SOLV stock is 12.25%.
- What is the 3Y average net profit margin for Solventum Corporation (SOLV)?
- The 3Y average net profit margin for SOLV stock is 14.36%.
- What is the 5Y average net profit margin for Solventum Corporation (SOLV)?
- The 5Y average net profit margin for SOLV stock is 15.15%.
- What is the 10Y average net profit margin for Solventum Corporation (SOLV)?
- The 10Y average net profit margin for SOLV stock is 15.15%.
- What is the 15Y average net profit margin for Solventum Corporation (SOLV)?
- The 15Y average net profit margin for SOLV stock is 15.15%.
- What is the 20Y average net profit margin for Solventum Corporation (SOLV)?
- The 20Y average net profit margin for SOLV stock is 15.15%.
Solventum Corporation Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 18.69% |
| 2024-12-31 | 5.80% |
| 2023-12-31 | 16.42% |
| 2022-12-31 | 16.52% |
| 2021-12-31 | 17.87% |
| 2020-12-31 | 15.63% |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson